Evidence map›Paper›PMID 29977015›Full record

ArticleLeukemia2019

Time resolved quantitative phospho-tyrosine analysis reveals Bruton's Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors.

Pankaj Dwivedi, David E Muench, Michael Wagner, Mohammad Azam, H Leighton Grimes, Kenneth D Greis

Abstract read
In one paragraph

Article in Leukemia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 4 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 4 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Purification and membrane interactions of human KCNQ1Biochimica et biophysica acta. Biomembranes · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pankaj DwivediDepartment of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0002-7666-9216
David E MuenchDivision of Immunobiology and Center for Systems Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Michael WagnerDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Mohammad AzamDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
H Leighton GrimesDivision of Immunobiology and Center for Systems Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. lee.grimes@cchmc.org.ORCID http://orcid.org/0000-0001-8162-6758
Kenneth D GreisDepartment of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA. greiskd@ucmail.uc.edu.
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
ENVIRONMETAL CARCINOGENESIS AND MUTAGENESIST32ES007250 · NIEHS · UNIVERSITY OF CINCINNATI · PI MILLER, WILLIAM E · 1988 to 2024
$11.9M
A rapid spontaneous murine model of CN-AMLR01CA196658 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI GRIMES, H. LEIGHTON · 2016 to 2018
$2.2M
Mechanism of non-oncogene addictionR01CA211594 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI AZAM, MOHAMMAD · 2018 to 2022
$1.8M
Improved therapeutic approaches for hematological disorder treated with tyrosineR01CA155091 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI AZAM, MOHAMMAD · 2012 to 2016
$1.6M
Enhanced proteomics capabilities for quantitation of proteins with a triple quadS10RR027015 · NCRR · UNIVERSITY OF CINCINNATI · PI GREIS, KENNETH DONALD · 2010 to 2010
$426k
NCI NIH HHS R01 CA155091NCI NIH HHS R01 CA196658NCI NIH HHS R01 CA211594NCRR NIH HHS S10 RR027015NIEHS NIH HHS P30 ES006096NIEHS NIH HHS T32 ES007250U.S. Department of Health & Human Services | National Institutes of Health (NIH) CA196658U.S. Department of Health & Human Services | National Institutes of Health (NIH) ES007250-06U.S. Department of Health & Human Services | NIH | National Center for Research Resources (NCRR) RR027015-01
6 · The paper itself

Abstract

Granulocyte-colony stimulating factor receptor (G-CSFR) controls myeloid progenitor proliferation and differentiation to neutrophils. Mutations in CSF3R (encoding G-CSFR) have been reported in patients with chronic neutrophilic leukemia (CNL) and acute myeloid leukemia (AML); however, despite years of research, the malignant downstream signaling of the mutated G-CSFRs is not well understood. Here, we used a quantitative phospho-tyrosine analysis to generate a comprehensive signaling map of G-CSF induced tyrosine phosphorylation in the normal versus mutated (proximal: T618I and truncated: Q741x) G-CSFRs. Unbiased clustering and kinase enrichment analysis identified rapid induction of phospho-proteins associated with endocytosis by the wild type G-CSFR only; while G-CSFR mutants showed abnormal kinetics of canonical Stat3, Stat5, and Mapk phosphorylation, and aberrant activation of Bruton's Tyrosine Kinase (Btk). Mutant-G-CSFR-expressing cells displayed enhanced sensitivity (3-5-fold lower IC50) for ibrutinib-based chemical inhibition of Btk. Primary murine progenitor cells from G-CSFR-Q741x knock-in mice validated activation of Btk by the mutant receptor and retrovirally transduced human CD34

Indexed as

MutationAdenineAgammaglobulinaemia Tyrosine KinaseAnimalsCell ProliferationCells, CulturedCell Transformation, NeoplasticHumansLeukemia, Myeloid, AcuteLeukemia, Neutrophilic, ChronicMicePhosphoproteinsPhosphorylationPiperidinesPrecursor Cells, B-LymphoidProtein-Tyrosine KinasesAdenineAgammaglobulinaemia Tyrosine KinaseBTK protein, humanBtk protein, mouseibrutinibPhosphoproteinsPiperidinesProtein-Tyrosine KinasesProteomePyrazolesPyrimidinesReceptors, Granulocyte Colony-Stimulating Factor

Identifiers

PMID29977015
PMCPMC6320735
OpenAlexW2809735854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.